Valiant Organics Limited

Valiant Organics Presents Investor Presentation at 21st AGM

Valiant Organics Limited held its 21st AGM on September 29, 2026, presenting an investor presentation. The company is a leading global chlorophenol derivatives manufacturer and domestic PNA producer. FY26 revenue was ₹739 crore with a 13.64% EBITDA margin. Key revenue drivers include Hydrogenation and Ammonolysis chemistries, serving Dyes & Pigments, Agro Chemicals, and Pharma sectors.

Valiant Organics Limited Holds 21st AGM on Sept 29, 2026; Discusses FY26 Performance

Valiant Organics Limited held its 21st AGM on September 29, 2026. For FY2025-26, the company reported revenue of ₹738.38 crore and PAT of ₹34.36 crore, up from a loss in the prior year. Key resolutions included director re-appointments and approval of related party transactions.

Valiant Organics Limited: Trading Window Closed for Financial Results

Valiant Organics Limited will close its trading window from October 01, 2026. The window will reopen 48 hours after the declaration of financial results for the quarter and half-year ended September 30, 2026, in compliance with SEBI regulations.

Valiant Organics Announces 21st AGM on Sep 29, 2026, via Video Conference

Valiant Organics Limited will hold its 21st Annual General Meeting on September 29, 2026, via video conference. The e-voting period is from September 25 to September 28, 2026. The Annual Report for FY 2025-26 has been dispatched.

Valiant Organics submits FY26 Business Responsibility and Sustainability Report

Valiant Organics Limited has filed its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's operations in chlorophenols and benzene-based specialty chemicals, serving agrochemicals, dyes, pharmaceuticals, and cosmetics sectors. The company has 670 employees and 239 workers. It also disclosed a pending appeal for an ₹87.9 lakh tax penalty.

Valiant Organics Announces 21st AGM on Sep 29, 2026, to Discuss FY26 Annual Report

Valiant Organics Limited will hold its 21st Annual General Meeting (AGM) on September 29, 2026. The company will also present its Annual Report for the Financial Year 2025-26 during the virtual meeting. The AGM and report details are available on the company's website.

Valiant Organics Announces 21st AGM on September 29, 2026

Valiant Organics Limited will hold its 21st Annual General Meeting on September 29, 2026, at 11:30 AM IST. The meeting will be conducted virtually via Video Conferencing (VC) / Other Audio Visual Means (OAVM).

Valiant Organics Q1 FY27 Revenue Climbs 13.3% YoY to ₹2,315 Mn, EBITDA Surges 67.7%

Valiant Organics Limited reported Q1-FY27 revenue of ₹2,315 million, up 13.3% YoY. EBITDA surged 67.7% to ₹416 million with margins at 17.97%. PAT increased to ₹293 million, and EPS was ₹10.44. The company highlighted improved margins and operational efficiencies.

Valiant Organics Publishes Q1 FY27 Financial Results and IEPF Notice

Valiant Organics Limited published its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company also issued a notice regarding the transfer of unclaimed dividends to the IEPF.

Valiant Organics Publishes Q1 FY27 Financial Results and IEPF Notice

Valiant Organics Limited announced its standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. The company also issued a notice regarding the transfer of unclaimed dividends for FY 2018-19 and FY 2019-20 to the IEPF by November 6, 2026, and December 15, 2026, respectively. Shareholders must claim by October 30, 2026.

Valiant Organics Board Approves Q1 FY27 Results, Reappoints MD, and Approves Office Shift

Valiant Organics reported Q1 FY27 results. The Board reappointed Shri Sathiababu K. Kallada as MD for three years from May 24, 2027. The company also approved shifting its registered office to Tarapur, Palghar, subject to shareholder approval.

Valiant Organics Board Approves Q1 FY27 Results, Reappoints MD, Shifts Office

Valiant Organics reported Q1 FY27 consolidated revenue of ₹23,481.61 lakhs and net profit of ₹2,926.33 lakhs. The Board reappointed Shri Sathiababu K. Kallada as MD for three years from May 24, 2027. The registered office will shift from Mumbai to Palghar, subject to shareholder approval.

Valiant Organics Board Approves Q1 FY27 Results & Reappoints MD

Valiant Organics reported Q1 FY27 results with consolidated profit after tax at ₹2,926.33 lakhs. The Board re-appointed Shri Sathiababu K. Kallada as Managing Director for three years from May 24, 2027. The registered office will be shifted to Tarapur, Palghar, subject to shareholder approval.

Valiant Organics Board Meeting on Aug 12 to Approve Q1 FY27 Results

Valiant Organics Limited will hold a Board Meeting on August 12, 2026, to approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The trading window will be closed until August 14, 2026.

Valiant Organics: CRISIL revises outlook to 'Stable' from 'Negative', reaffirms ratings

CRISIL Ratings has revised Valiant Organics Limited's long-term rating outlook to 'Stable' from 'Negative', reaffirming it at 'Crisil A-'. The short-term rating is reaffirmed at 'Crisil A2+'. This reflects strengthening business risk profile, higher operating margins, and steady revenue growth, with FY26 revenue at ₹745.68 crore and margin at 12.75%.

Valiant Organics: Trading Window Closed from July 1 for Q1 FY27 Results

Valiant Organics Limited will close its trading window from July 1, 2026. The window will reopen 48 hours after the declaration of financial results for the quarter ended June 30, 2026. This is in compliance with SEBI regulations.

Valiant Organics Cancels Postal Ballot, Halts Dhanvallabh Ventures LLP Exit

Valiant Organics Limited has canceled its postal ballot process and related party transaction concerning its exit from Dhanvallabh Ventures LLP. The Board of Directors made this decision on June 18, 2026, and the associated electronic voting event is withdrawn.

Valiant Organics Board Decides Not to Proceed with Dhanvallabh Ventures LLP Cessation

Valiant Organics Limited's Board has decided not to proceed with its cessation as a partner of Dhanvallabh Ventures LLP. The related postal ballot and electronic voting processes have been cancelled. Further deliberations by the board are expected.

Valiant Organics FY26 PAT Turns Positive at ₹332 Cr, Revenue Rises 3% to ₹7,388 Cr

Valiant Organics reported a turnaround in FY26 with PAT turning positive at ₹332 million, compared to a loss of ₹34 million in FY25. Revenue grew 3% to ₹7,388 million. EBITDA margins expanded to 11.94% from 7.47%. Q4 FY26 PAT was ₹157 million.

Valiant Organics Publishes Postal Ballot Notice in Newspapers

Valiant Organics Limited has published a notice regarding a postal ballot in the Financial Express and Mumbai Lakshadeep newspapers on May 23, 2026, in compliance with SEBI regulations.

Valiant Organics to seek member approval for cessation from Dhanvallabh Ventures LLP

Valiant Organics Limited is seeking member approval via postal ballot and e-voting for its cessation as a partner in subsidiary Dhanvallabh Ventures LLP. The transaction includes an off-market transfer of 1.86 crore shares of Valiant Laboratories Ltd and a payment of ₹6.34 crore. E-voting period: May 23 to June 21, 2026.

Valiant Organics Clarifies DVLLP Partnership Cessation Settlement Terms

Valiant Organics Limited clarifies settlement terms for exiting DVLLP. DVLLP will transfer 1,86,07,531 Valiant Laboratories shares and ₹6.34 crore to Valiant Organics. This follows an internal review, correcting previous disclosures on the transaction.

Valiant Organics exits DVLLP, to receive Valiant Laboratories shares

Valiant Organics Limited's Board approved exiting Dhanvallabh Ventures LLP (DVLLP). The company will receive 1,86,07,531 equity shares of Valiant Laboratories Limited as consideration. This material related party transaction will be at fair market value. DVLLP's FY26 turnover was ₹0.3756 crore and net worth was ₹83.79 crore.

Valiant Organics Publishes Audited Financial Results for Q4FY26

Valiant Organics Limited published its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The publication occurred on May 17, 2026, in The Financial Express and Mumbai Lakshadeep newspapers.

Valiant Organics Grants 19,500 Stock Options Under ESOP Scheme 2022

Valiant Organics Limited has approved the grant of 19,500 stock options to employees under its ESOP Scheme 2022. The exercise price is ₹10 per option. 15,000 options vest after one year, with the rest tied to performance criteria. Options are exercisable within three years post-vesting.

Valiant Organics Explores Restructuring Options for Synergies

Valiant Organics Limited's Board approved exploring restructuring options with subsidiaries and associates. The move aims to achieve synergies, simplify the structure, and unlock shareholder value. The evaluation process is underway and will involve further Board considerations.

Valiant Organics Approves Q4 FY26 Results, Reappoints Cost & Internal Auditors

Valiant Organics Limited approved its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company identified Pharma Business as a new reportable segment. Smt. Ketki D. Visariya was reappointed as Cost Auditor and M/s. Manish Modi & Associates as Internal Auditor for FY 2026-27.

Valiant Organics Declares Audited FY26 Financial Results, Appoints Cost and Internal Auditors

Valiant Organics Limited's Board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Pharma Business was identified as a new reportable segment. Smt. Ketki D. Visariya was re-appointed Cost Auditor and M/s. Manish Modi & Associates as Internal Auditor for FY 2026-27.

Valiant Organics Limited Issues Public Notices on Share Certificates and Investor Campaigns

Valiant Organics Limited is participating in the 'Saksham Niveshak' campaign to help shareholders claim unpaid dividends. The company is also issuing notices regarding lost share certificates and ownership transfers, urging stakeholders to submit objections within stipulated timelines.

Valiant Organics Launches "Saksham Niveshak" Campaign for Unclaimed Dividends

Valiant Organics is relaunching the "Saksham Niveshak" campaign from April 01, 2026, to July 09, 2026, to help shareholders claim unpaid or unclaimed dividends. Shareholders must update KYC details and submit necessary forms to their RTA or DP to receive payments and avoid transfer to IEPF.

Valiant Organics: Certificate confirms no dematerialization requests for Q4FY26

Valiant Organics Limited received a certificate confirming no dematerialization requests for the quarter ended March 31, 2026. All securities are held in dematerialized form, making Regulation 74(5) inapplicable.

Valiant Organics: Trading Window Closed from April 1, 2026 for Q4 FY26 Results

Valiant Organics Limited will close its trading window from April 1, 2026. The window will reopen 48 hours after the declaration of financial results for the quarter and year ended March 31, 2026, in compliance with SEBI regulations.

Valiant Organics Limited Clarifies No Price Sensitive Information Drives Stock Movement

Valiant Organics Limited clarified to BSE and NSE that there is no undisclosed price-sensitive information affecting its stock movement. The company believes the price and volume changes are market-driven. They reiterated their commitment to timely disclosures as per SEBI regulations.

Valiant Organics Q3 FY26 Results: Revenue ₹5,210 Mn, EBITDA ₹616 Mn, PAT ₹175 Mn

Valiant Organics Limited reported Q3 FY26 consolidated revenue of ₹5,210 million and EBITDA of ₹616 million. For the nine-month period, revenue was ₹5,210 million, with EBITDA at ₹616 million, up 84.4% YoY. PAT for 9M FY26 was ₹175 million, a turnaround from a loss in 9M FY25. The company also noted a gross profit margin expansion to 43% for 9M FY26.

Valiant Organics Ltd. Publishes Q3 FY26 Financial Results

Valiant Organics Limited published its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The Board of Directors approved these results on February 13, 2026. Newspaper publications were made on February 14, 2026.

Valiant Organics declares Q3 FY26 Unaudited Standalone & Consolidated Results

Valiant Organics reported its Q3 FY26 results. Standalone revenue from operations was ₹15,906.97 lakhs, with a net profit of ₹606.36 lakhs for the quarter. Consolidated revenue from operations stood at ₹15,927.02 lakhs, with a net profit of ₹364.45 lakhs for the quarter. The nine-month standalone net profit was ₹1,923.82 lakhs, and consolidated net profit was ₹1,750.92 lakhs.

Valiant Organics Q3 FY26 Standalone Profit Up 8.4% to ₹606.36 Lakhs

Valiant Organics reported Q3 FY26 standalone net profit of ₹606.36 lakhs, up 8.4% year-on-year. Revenue from operations was ₹15,906.97 lakhs. Nine-month standalone profit reached ₹1,923.82 lakhs. Consolidated profit for Q3 FY26 was ₹364.45 lakhs. The company recognized an exceptional item of ₹572.08 lakhs related to an insurance claim.

Valiant Organics Clarifies Consolidated Financial Results Segment Details

Valiant Organics Limited clarified to the NSE that it operates as a single segment entity in chemical manufacturing. Consequently, no separate reportable business segments exist for consolidated financial statements. This addresses a deficiency noted in their results for the period ending September 30, 2025.

Valiant Organics: Reg 74(5) Certificate Not Applicable for Q3FY26

Valiant Organics Limited received a certificate stating Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 is not applicable for the quarter ended December 31, 2025. All securities are held in dematerialized form, with no requests for dematerialization or cancellation received.

Valiant Organics: Trading Window Closed Jan 1 For Q3 FY26 Results

Valiant Organics Limited will close its trading window from January 1, 2026, for Directors, Promoters, and Designated Persons. The window will reopen 48 hours after the declaration of financial results for the quarter ending December 31, 2025.

Valiant Organics Reports Strong Turnaround in Q2 FY26 with Return to Profitability

Valiant Organics reported a strong Q2 FY26 turnaround, returning to ₹57 million (₹5.7 crore) PAT from a loss. Revenue grew 10.2% in H1, driven by improved margins and operational efficiency.

Valiant Organics reports unaudited Q2 & H1 FY26 financial results

Valiant Organics reported Q2 & H1 FY26 unaudited standalone and consolidated financial results, showing a return to profitability compared to the previous year, despite a sequential quarterly dip.

Valiant Organics Approves Unaudited Financial Results, Senior Management Changes

Valiant Organics approves unaudited financial results for the quarter ended September 30, 2025, and includes several officers in the list of Senior Management Personnel.

Valiant Organics Approves Unaudited Results, Senior Management Changes, and Funding Update

Valiant Organics approved unaudited financial results for the quarter ended September 30, 2025, included new officers in senior management, and decided not to proceed with fund raising due to arranged funding.

Valiant Organics reports profitable Q2 & H1 FY26; appoints 10 Senior Management; defers fund-raising.

Valiant Organics announced profitable Q2 & H1 FY26 results, a significant turnaround from losses. It appointed 10 senior managers and deferred fund-raising, having secured banking finance.

Valiant Organics reports Q2 and H1 FY26 profit, appoints 10 SMPs, and secures banking funds

Valiant Organics reported a turnaround to profit for Q2 and H1 FY26. The company appointed 10 Senior Management Personnel and decided against a fundraising proposal, having secured banking funds.

Valiant Organics Board Meeting on November 13, 2025, to Consider Q2/H1 FY26 Results and Fund Raising

Valiant Organics' board to meet on November 13, 2025, to approve Q2/H1 FY26 financial results and discuss a fund-raising proposal. Trading window closed until November 15, 2025.

Valiant Organics receives 'CRISIL ESG 46' rating for FY 2024-25

Valiant Organics received an independent 'CRISIL ESG 46' rating for FY 2024-25, based on publicly available data, as disclosed on October 10, 2025.

Valiant Organics Submits SEBI Regulation 74(5) Certificate for Q2/H1 FY26

Valiant Organics submitted the Regulation 74(5) Certificate for Q2/H1 FY26, confirming compliance with dematerialisation processes for the quarter and half year ended September 30, 2025.

Valiant Organics Re-appoints Directors, Appoints Secretarial Auditor